Peginterferon α-2b plus an anti-PD-1
XMYY-2025KY199-01
Unknown small_molecule active
Quick answer
Peginterferon α-2b plus an anti-PD-1 for Advanced Solid Tumors is a Unknown program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Advanced Solid Tumors
- Phase
- Unknown
- Modality
- small_molecule
- Status
- active